MOBIX LABS, INC (MOBX) Form 424B3 — Nov 16, 2026
Mobix Labs filed Prospectus Supplement No. 3 to its Form S-1, incorporating an 8-K dated November 13, 2026 covering three major events: a 1-for-7 reverse stock split, termination of its merger agreement with Special Project Delivery, and preliminary fiscal Q4 results. The 1-for-7 reverse split takes effect November 16, 2026, cutting Class A shares outstanding from roughly 23.6 million to about 3.4 million, explicitly to maintain Nasdaq's $1.00 minimum bid price compliance — a signal of listing distress. The merger with SPD was terminated amicably on November 12 after the parties failed to obtain a fairness opinion, with no termination fees payable.
Key figures
- Eps
- 0
- Revenue
- 1810000
- Offering Price
- 0.51
- Shares Offered
- 5000000
- Q4 revenue yoy
- -4%
- Gross margin q4
- 44.5%
- Gross profit q4
- 804000
- Accounts payable
- 4880000
- Operating loss q4
- 6560000
- Total liabilities
- 29630000
- Gross profit growth
- 688%
- Reverse split ratio
- 1-for-7
- Stockholders equity
- 4870000
- Fiscal 2026 net loss
- 41860000
- Fiscal 2026 stock comp
- 12300000
- Net loss prior quarter
- 16800000
- Total liabilities decline
- 21%
- Gross margin prior quarter
- 12.9%
- Q4 revenue sequential growth
- 129%
- Shares outstanding pre split
- 23646570
- Shares outstanding post split
- 3378082
- Product revenue sequential growth
- 171%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.